United States · FDA National Drug Code directory
APRISO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65649-103_5a0ee848-80a0-294e-e063-6394a90a08aa
- Product NDC
- 65649-103
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- mesalamine
- Labeler
- Salix Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20081031
- Source listing expiry
- 20271231
Source-listed ingredients
- MESALAMINE — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (65649-103-01) / 4 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 65649-103-01
- 1 BOTTLE in 1 CARTON (65649-103-02) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 65649-103-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →